Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL1934271

CNc1ccccc1.O=S(=O)(O)C(F)(F)F

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.56
HSD17B10 Q99714 2/20 0.48
ALDH1A1 P00352 2/20 0.48
HPGD P15428 2/20 0.48
TP53 P04637 1/20 0.48
CYP3A4 P08684 1/20 0.48
THRB P10828 1/20 0.48
ALOX15 P16050 1/20 0.48
CASP1 P29466 1/20 0.48
RECQL P46063 1/20 0.48
HIF1A Q16665 1/20 0.48
KEAP1 Q14145 1/20 0.42
PDK1 Q15118 2/20 0.41
PDK2 Q15119 2/20 0.41
PDK3 Q15120 2/20 0.41
PDK4 Q16654 2/20 0.41
ACP1 P24666 2/20 0.40
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA12 O43570 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11368859 0.85 TSHR (0.70) TSHRHSD17B10ALDH1A1HPGDTP53
Sulfuric Acid SCHEMBL4577786 0.85 TSHR (0.70) TSHRHSD17B10ALDH1A1HPGDTP53
Diphenylamine SCHEMBL724958 0.83 HSD17B10 (0.52) TSHRHSD17B10ALDH1A1HPGDCYP3A4
Sulfuric Acid SCHEMBL8026090 0.81 TSHR (0.64) TSHRHSD17B10ALDH1A1HPGDTP53
SCHEMBL22462534 0.81 TSHR (0.70) TSHRHSD17B10ALDH1A1HPGDTP53
Trifluoromethanesulfonic Acid SCHEMBL27550260 0.79 LMNA (0.47) ALDH1A1KEAP1PDK1PDK2PDK3
Trifluoroacetic Acid SCHEMBL9333894 0.79 TSHR (0.61) TSHRHSD17B10TP53CYP3A4PDK1
Trifluoroacetic Acid SCHEMBL584478 0.79 TSHR (0.61) TSHRHSD17B10TP53CYP3A4PDK1
Diphenylamine SCHEMBL16291173 0.78 PTGS1 (0.42) TSHRHSD17B10ALDH1A1HPGDALOX15
Trifluoromethanesulfonic Acid SCHEMBL25226663 0.78 TSHR (0.46) TSHRALDH1A1HPGDTP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102702278-B Method for synthesizing clindamycin 3,4-isopropylidene UNIV ZHEJIANG TECHNOLOGY 2015-01-28 CN claimed
CN-102702278-A Method for synthesizing clindamycin 3,4-isopropylidene UNIV ZHEJIANG TECHNOLOGY 2012-10-03 CN claimed
CN-102702278-B Method for synthesizing clindamycin 3,4-isopropylidene UNIV ZHEJIANG TECHNOLOGY 2015-01-28 CN disclosed
US-8921572-B2 Method for producing 5,5-disubstituted 4,5-dihydroisoxazol-3-thiocarboxamidine salts BASF SE (DE) 2014-12-30 US disclosed
US-20120264947-A1 Method for Producing 5,5-Disubstituted 4,5-Dihydroisoxazol-3-Thiocarboxamidine Salts BASF SE (DE) 2012-10-18 US disclosed
EP-2504322-A1 METHOD FOR PRODUCING 5,5-DISUBSTITUTED 4,5-DIHYDROISOXAZOL-3-THIOCARBOXAMIDINE SALTS BASF SE (DE) 2012-10-03 EP disclosed
CN-102702278-A Method for synthesizing clindamycin 3,4-isopropylidene UNIV ZHEJIANG TECHNOLOGY 2012-10-03 CN disclosed
WO-2011063842-A1 METHOD FOR PRODUCING 5,5-DISUBSTITUTED 4,5-DIHYDROISOXAZOL-3-THIOCARBOXAMIDINE SALTS BASF SE (DE) 2011-06-03 WO disclosed
US-20070048660-A1 Resist composition, method for forming resist pattern, semiconductor device and method for manufacturing thereof FUJITSU LIMITED (JP) 2007-03-01 US disclosed
EP-1757983-A1 Resist composition, method for forming resist pattern, semiconductor device and method for manufacturing thereof Fujitsu Ltd. (JP) 2007-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120264947-A1 Method for Producing 5,5-Disubstituted 4,5-Dihydroisoxazol-3-Thiocarboxamidine Salts DHX15, DHX35, HDHD5 TSHR 32/4885HSD17B10 2789/4885ALDH1A1 602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.